87 related articles for article (PubMed ID: 15345470)
1. Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein.
Hung DY; Siebert GA; Chang P; Burczynski FJ; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G93-100. PubMed ID: 15345470
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites.
Hung DY; Burczynski FJ; Chang P; Lewis A; Masci PP; Siebert GA; Anissimov YG; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G423-33. PubMed ID: 12444013
[TBL] [Abstract][Full Text] [Related]
3. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid oxidation is decreased in the liver of ovariectomized rats.
Paquette A; Chapados NA; Bergeron R; Lavoie JM
Horm Metab Res; 2009 Jul; 41(7):511-5. PubMed ID: 19241328
[TBL] [Abstract][Full Text] [Related]
5. Mild steatosis impairs functional recovery after liver resection in an experimental model.
Veteläinen R; Bennink RJ; van Vliet AK; van Gulik TM
Br J Surg; 2007 Aug; 94(8):1002-8. PubMed ID: 17497653
[TBL] [Abstract][Full Text] [Related]
6. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids.
Marsman HA; de Graaf W; Heger M; van Golen RF; Ten Kate FJ; Bennink R; van Gulik TM
Br J Surg; 2013 Apr; 100(5):674-83. PubMed ID: 23456631
[TBL] [Abstract][Full Text] [Related]
7. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of reduced-size orthotopic liver transplantation with fatty grafts and its potential regeneration in rats.
Sheng Y; Jiahong D; Benli H
Arch Med Res; 2009 Apr; 40(3):146-55. PubMed ID: 19427964
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
10. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
[TBL] [Abstract][Full Text] [Related]
11. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
12. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.
Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F
Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345
[TBL] [Abstract][Full Text] [Related]
13. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].
Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
17. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
[TBL] [Abstract][Full Text] [Related]
19. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
20. Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation.
Hung DY; Siebert GA; Chang P; Whitehouse MW; Fletcher L; Crawford DH; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G343-51. PubMed ID: 16166348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
